Cargando…
Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
PURPOSE: The purpose of the study was to describe macular changes in treatment-naïve eyes with Eales disease using spectral domain optical coherence tomography (SD-OCT). METHODS: A cross-sectional study was done on 79 eyes of 66 patients with Eales disease. Best-corrected visual acuity (BCVA), slit-...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859602/ https://www.ncbi.nlm.nih.gov/pubmed/29480258 http://dx.doi.org/10.4103/ijo.IJO_845_17 |
_version_ | 1783307852697305088 |
---|---|
author | Goel, Neha Kumar, Vinod Arora, Supriya Jain, Pooja Ghosh, Basudeb |
author_facet | Goel, Neha Kumar, Vinod Arora, Supriya Jain, Pooja Ghosh, Basudeb |
author_sort | Goel, Neha |
collection | PubMed |
description | PURPOSE: The purpose of the study was to describe macular changes in treatment-naïve eyes with Eales disease using spectral domain optical coherence tomography (SD-OCT). METHODS: A cross-sectional study was done on 79 eyes of 66 patients with Eales disease. Best-corrected visual acuity (BCVA), slit-lamp biomicroscopy (SLB), indirect ophthalmoscopy, fundus fluorescein angiography (FFA), and quantitative (central macular thickness [CMT]) and qualitative analysis on SD-OCT were performed. RESULTS: Forty-six (58.2%) eyes had macular involvement as assessed with SD-OCT, while in 33 (41.8%) eyes, macula was not affected. Macular edema was the most common feature when macula was affected followed by epiretinal membrane. Mean CMT was higher (315.3 ± 102.3 μm) in eyes with macular involvement than those without it (243.8 ± 19.3 μm). Eyes with active vasculitis involving larger vessels and neovascularization had greater chance of macular involvement. SLB and FFA alone missed 28.3% and 50% eyes with macular abnormalities on SD-OCT, respectively. CONCLUSION: While the clinical description of Eales disease points mainly to a peripheral location, macular involvement can be commonly picked up when SD-OCT is used. Macular involvement when present is associated with a poorer BCVA. |
format | Online Article Text |
id | pubmed-5859602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-58596022018-03-23 Spectral domain optical coherence tomography evaluation of macular changes in Eales disease Goel, Neha Kumar, Vinod Arora, Supriya Jain, Pooja Ghosh, Basudeb Indian J Ophthalmol Original Article PURPOSE: The purpose of the study was to describe macular changes in treatment-naïve eyes with Eales disease using spectral domain optical coherence tomography (SD-OCT). METHODS: A cross-sectional study was done on 79 eyes of 66 patients with Eales disease. Best-corrected visual acuity (BCVA), slit-lamp biomicroscopy (SLB), indirect ophthalmoscopy, fundus fluorescein angiography (FFA), and quantitative (central macular thickness [CMT]) and qualitative analysis on SD-OCT were performed. RESULTS: Forty-six (58.2%) eyes had macular involvement as assessed with SD-OCT, while in 33 (41.8%) eyes, macula was not affected. Macular edema was the most common feature when macula was affected followed by epiretinal membrane. Mean CMT was higher (315.3 ± 102.3 μm) in eyes with macular involvement than those without it (243.8 ± 19.3 μm). Eyes with active vasculitis involving larger vessels and neovascularization had greater chance of macular involvement. SLB and FFA alone missed 28.3% and 50% eyes with macular abnormalities on SD-OCT, respectively. CONCLUSION: While the clinical description of Eales disease points mainly to a peripheral location, macular involvement can be commonly picked up when SD-OCT is used. Macular involvement when present is associated with a poorer BCVA. Medknow Publications & Media Pvt Ltd 2018-03 /pmc/articles/PMC5859602/ /pubmed/29480258 http://dx.doi.org/10.4103/ijo.IJO_845_17 Text en Copyright: © 2018 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Goel, Neha Kumar, Vinod Arora, Supriya Jain, Pooja Ghosh, Basudeb Spectral domain optical coherence tomography evaluation of macular changes in Eales disease |
title | Spectral domain optical coherence tomography evaluation of macular changes in Eales disease |
title_full | Spectral domain optical coherence tomography evaluation of macular changes in Eales disease |
title_fullStr | Spectral domain optical coherence tomography evaluation of macular changes in Eales disease |
title_full_unstemmed | Spectral domain optical coherence tomography evaluation of macular changes in Eales disease |
title_short | Spectral domain optical coherence tomography evaluation of macular changes in Eales disease |
title_sort | spectral domain optical coherence tomography evaluation of macular changes in eales disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859602/ https://www.ncbi.nlm.nih.gov/pubmed/29480258 http://dx.doi.org/10.4103/ijo.IJO_845_17 |
work_keys_str_mv | AT goelneha spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease AT kumarvinod spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease AT arorasupriya spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease AT jainpooja spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease AT ghoshbasudeb spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease |